← Archive

EPSDT's Forty-Year Promise: Every Medicaid Child on a Waiver Waitlist Is Entitled to Behavioral Health Care. Almost No Company Is Actually Delivering It.

The EPSDT entitlement for HCBS-waitlisted children has been in statute for sixty years. The operational infrastructure to deliver on it has not been built. Three companies are closer than any others.

Pediatric Health Dispatch — Deep Dispatch | July 10, 2026

The Guarantee That Predates the Internet, and Why It Still Isn't Working

The Early and Periodic Screening, Diagnostic, and Treatment benefit has been federal law since 1967. It covers every child and adolescent enrolled in Medicaid and CHIP: roughly 40 million young people as of 2026. The core obligation has not changed across six decades. States must provide all medically necessary health services to enrolled children. They cannot impose hard limits on the amount, duration, or scope of covered care. If a physician or qualified clinician determines a service is medically necessary, EPSDT says it must be covered. The language is not permissive. It is a mandate.

CMS's May 2026 EPSDT Coverage Guide is not a new policy. It is the most current technical-assistance document for state Medicaid administrators, consolidating guidance on screening, diagnosis, treatment, prior authorization, managed care, and quality reporting. But it contains one clarification worth marking: it explicitly states that children on HCBS waiver waiting lists remain entitled to EPSDT-covered medically necessary services, including behavioral health services delivered in home and community settings. States cannot deny Section 1905(a) services because a Medicaid-enrolled child is on a waiting list for something more comprehensive.

This matters because HCBS waiver waiting lists are long and growing. Medicaid's home and community-based services waivers provide enhanced supports for children with complex developmental, behavioral, and medical needs beyond what standard Medicaid covers. In most states those waitlists run for years, sometimes well over a decade for autism and developmental disability waivers. The children on those lists are not waiting for a convenience. They are waiting for care their families need and federal law has always said they were entitled to under the baseline EPSDT benefit. The May 2026 guidance made CMS's position explicit: states cannot let the existence of a waiver waiting list function as a de facto denial of standard Medicaid services.

The May 2026 guide also addressed school-based service delivery directly. It confirmed that school-employed clinicians, school clinics, and community providers contracted into school settings can all deliver EPSDT-billable services in those settings. That is not a new rule, but its explicit inclusion in a document aimed at state Medicaid administrators signals that CMS is connecting the dots: the services children need, the community settings where children already are, and the reimbursement infrastructure that should cover them can coexist. The operational question is why they so often don't.

The Three Gaps Between the Law and the Living Room

The EPSDT floor has three structural gaps. They are individually documented and collectively underappreciated. Their interaction is what makes the access failure durable.

The first gap is rate inadequacy. Medicaid reimbursement rates for behavioral health and developmental services are set by states, and in most states they are set low enough to make community-based delivery economically marginal at scale. A provider delivering behavioral therapy in a child's home carries higher travel and coordination costs than a clinic-based provider. Virtual delivery reduces the geographic constraint without eliminating the rate problem. When Backpack Healthcare says it holds in-network contracts with major Medicaid MCOs across Georgia, Illinois, Maryland, Michigan, and Virginia, it is not claiming those contracts make community-based pediatric behavioral health easy to operate at margin. It is claiming the company has built a viable model at rates many providers would decline. That is a real operational achievement, and it is not infinitely replicable without structural rate reform or volume economics that come only with significant scale.

The second gap is network adequacy. The communities with the longest HCBS waiting lists are the same communities with the fewest behavioral health providers available to deliver EPSDT services in the meantime. Pediatric psychiatrists, licensed clinical social workers, and BCBAs are concentrated in urban and suburban areas. Rural communities and under-resourced urban neighborhoods have both the highest rates of HCBS-eligible children and the thinnest provider networks. States are required to maintain network adequacy standards under managed care, but enforcement varies. Virtual delivery is the practical solution to this gap. A company that can deliver behavioral therapy via a screen, with Medicaid billing, into a community where no in-person provider operates, is not a convenience tool. It is a network adequacy solution for the most underserved children in the EPSDT system.

The third gap is measurement. Pediatric HCBS services have had almost no standardized quality-measurement infrastructure. On May 8, 2026, CMS opened public comment on the first-ever quality measures specifically designed for children, youth, and young adults receiving Medicaid HCBS services. The measure set is being developed with Mathematica and the Human Services Research Institute. CMS framed it as a foundation for quality improvement rather than immediate enforcement. But the direction is unambiguous: CMS is building the measurement scaffolding for pediatric community-based care. Companies that can document outcomes, access, care coordination, and family experience for children with high-acuity needs will be better positioned in state procurement and MCO contracting than those that cannot.

These three gaps interact. Low rates discourage entry into markets with poor networks. Poor networks produce no outcome data for measurement. No measurement creates no accountability for the access failures that rates and networks cause. Breaking the cycle requires a company willing to accept initially thin margins, deliver in network-thin geographies, and build the documentation infrastructure to demonstrate outcomes in a landscape that has never demanded them. That is a harder business to build than a consumer teletherapy app. It is also a more defensible one, because the companies that survive this build will have assets that cannot be acquired off a shelf: MCO relationships, community-based delivery capacity, and outcome documentation built across years of Medicaid contracting.

Who Is Closest to the Infrastructure That Matters

Three companies in the current pediatric behavioral and developmental health cohort have moved meaningfully toward the operational stack the EPSDT floor requires. None has fully assembled it. All three are worth tracking for distinct reasons.

Backpack Healthcare is the most deliberately multi-channel Medicaid operator in the group. Its public partner pages now segment across three distribution surfaces: providers and health systems (where Backpack says it reaches most referrals to a clinician within three to five days), health plans (where it holds in-network contracts with major Medicaid MCOs in five states), and schools (where it says it supports more than 400,000 students through district partnerships, including a 2025 $3 million Maryland contract covering 150,000-plus students in Baltimore and Howard County). That three-channel structure is unusual. Most pediatric behavioral health companies pick one distribution strategy and optimize for it. Backpack has built all three, which means it can reach children through whichever access point is available: a school counselor's referral, a pediatrician's order, or a Medicaid plan enrollment. The EPSDT-relevant question about Backpack is whether its multi-channel, multi-state Medicaid model can expand to the states with the longest HCBS waiting lists and the weakest community-based provider networks.

Forta Health makes the most compelling case for the network adequacy gap. Operating across more than 40 states and accepting more than 300 insurance plans including Medicaid, Forta is the closest thing the autism sector has to a national virtual network. ABA therapy has historically been among the most difficult EPSDT services to access in under-resourced communities, because intensive ongoing clinical oversight is hard to staff in areas without clinic capacity. Forta's virtual model addresses the geographic constraint directly. Its parent-partnered, home-based structure also maps cleanly onto what the CMS EPSDT guidance describes as permissible community-based service delivery: care delivered in the home, with caregiver activation, billable under standard Medicaid. Whether Forta's model scales effectively to the highest-acuity developmental needs, not just autism cases with active families, is the open question in its favor.

Cortica is the most analytically interesting case because its value-based contract structure is the one most likely to resolve the rate adequacy problem at scale. Its cap table includes Morgan Health, Optum Ventures, and CVS Health Ventures: payer investors making a deliberate bet that autism and neurodevelopmental care will move from fragmented fee-for-service to outcomes-linked contracts. A value-based contract changes the rate adequacy calculation. Instead of billing Medicaid rates per unit of service, the company receives a per-member payment for an enrolled population and keeps margin from delivering care efficiently. If CMS's emerging HCBS quality-measure infrastructure eventually enables outcome-linked contracting for community-based pediatric services, Cortica's model looks less like a philosophical preference and more like preparation.

The ASPIRE model connects all three companies to a single federal thread. CMS's voluntary ten-year program, which will fund up to five states to build whole-child complex pediatric care infrastructure, requires assigning each child a single care coordinator, providing 24/7 clinical access with full clinical context, and addressing physical health, behavioral health, and social needs jointly. That description is, in operational terms, the infrastructure required to turn the EPSDT entitlement for HCBS-waitlisted children into delivered care. The NOFO for state applications has not yet been released, but when it arrives, the states with Backpack, Forta, or Cortica already contracted into their Medicaid networks will have a material implementation advantage over states building from scratch.

The HHS May 2026 posture on non-medication pediatric care adds one more layer. The administration's action plan on psychiatric prescribing explicitly calls for expanding access to psychotherapy, family support, and evidence-based non-medication care for children and adolescents. That posture favors therapy-first and family-activation models and raises the bar for medication-heavy pediatric psychiatry approaches. For the companies described above, which are all therapy- and behavioral-intervention-led rather than prescribing-led, this is a policy alignment that requires no pivot.

The EPSDT floor has been in statute for nearly sixty years. The measurement infrastructure to enforce it is only now being designed. The companies that build the operational stack to deliver on it (multi-state Medicaid contracts, community-based and virtual delivery, caregiver activation, outcome documentation) will not be waiting for policy to move in their favor. Policy already has.

What we're watching

• Whether CMS issues state plan amendment guidance or a compliance directive requiring states to actively implement the EPSDT entitlement for children on HCBS waiver waiting lists: this remains the escalation signal PHD has been tracking for this topic, and it would change the compliance calculus for every state Medicaid agency running developmental services through managed care organizations.
• CMS finalization of pediatric HCBS quality measures (public comment closed June 8, 2026): if CMS moves toward program-specific rulemaking incorporating these measures, it creates an outcome-documentation standard that will matter in state procurement and MCO contracting, and it will advantage companies that have already built that infrastructure over those that have not.
• The ASPIRE NOFO release and which states apply: the applicant pool will identify where community-based whole-child pediatric care has enough infrastructure to function at scale. Companies contracted in ASPIRE states will have a built-in implementation channel into the most significant federal pediatric care-delivery investment of the decade.

---